The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Interaction between Red Yeast Rice and CYP450 Enzymes/P-Glycoprotein and Its Implication for the Clinical Pharmacokinetics of Lovastatin
Abstract
Red yeast rice (RYR) can reduce cholesterol through its active component, lovastatin. This study was to investigate the pharmacokinetic properties of lovastatin in RYR products and potential RYR-drug interactions. Extracts of three registered RYR products (LipoCol Forte, Cholestin, and Xuezhikang) were more effective than pure lovastatin in inhibiting the activities of cytochrome P450 enzymes and P-glycoprotein. Among CYP450 enzymes, RYR showed the highest inhibition on CYP1A2 and CYP2C19, with comparable inhibitory potencies to the corresponding typical inhibitors. In healthy volunteers taking the RYR product LipoCol Forte, the pharmacokinetic properties of lovastatin and lovastatin acid were linear in the dose range of 1 to 4 capsules taken as a single dose and no significant accumulation was observed after multiple dosing. Concomitant use of one LipoCol Forte capsule with nifedipine did not change the pharmacokinetics of nifedipine. Yet, concomitant use of gemfibrozil with LipoCol Forte resulted in a significant increase in the plasma concentration of lovastatin acid. These findings suggest that the use of RYR products may not have effects on the pharmacokinetics of concomitant comedications despite their effects to inhibit the activities of CYP450 enzymes and P-gp, whereas gemfibrozil affects the pharmacokinetics of lovastatin acid when used concomitantly with RYR products.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“They identified red rice extracts containing the lovastatin-like compounds inhibited several of the drug metabolising cytochrome P450 enzymes and drug transporter P-glycoprotein activity more than pure lovastatin [90, 91].”
From The Use of Medications and Dietary Supplements by Masters Athletes—A Review (2022) · cites this paper as [90]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lu, Z., Kou, W., Du, B., Wu, Y., Zhao, S., Brusco, O. A., Morgan, J. M., & Capuzzi, D. M. (2008) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2008.02.056 · Cited by 315
Marked Variability of Monacolin Levels in Commercial Red Yeast Rice Products: Buyer Beware!
Gordon, R. Y., Cooperman, T., Obermeyer, W., & Becker, D. J. (2010) · Archives of Internal Medicine · doi:10.1001/archinternmed.2010.382 · Cited by 184 · cited 1×
“Interestingly, RYR products containing about 2–5mg of lovastatin have a comparable efficacy to 20mg of lovastatin in lowering blood cholesterol [2, 10– 12], suggesting additive and/or synergistic pharmacological effects of RYR components.”
Background
Research works printed but not linked: 42
- 10.1016/S0140-6736(07)61778-4 · DOI · Paper page
- 1999, American Journal of Clinical Nutrition, 69, 231, 10.1093/ajcn/69.2.231 · DOI · Paper page
- 10.1530/eje.1.02012 · DOI
- 10.1186/1749-8546-1-4 · DOI
- 10.1097/HJR.0b013e32801da137 · DOI
- 10.1097/FJC.0b013e31802d3a58 · DOI
- 2009, P and T, 34, 313
- 10.1155/2012/636547 · DOI
- 10.4065/83.7.758 · DOI
- 2009, Annals of Internal Medicine, 150, 830, 10.7326/0003-4819-150-12-200906160-00006 · DOI · Paper page
- 1980, Proceedings of the National Academy of Sciences of the United States of America, 77, 3957, 10.1073/pnas.77.7.3957 · DOI · Paper page
- 10.1016/0003-9861(91)90551-S · DOI
- 10.1124/dmd.104.002477 · DOI
- 10.1016/j.amjcard.2009.08.672 · DOI · Paper page
- 10.1016/j.amjcard.2009.10.045 · DOI
- 2002, Transplantation, 74, 1200, 10.1097/00007890-200210270-00028 · DOI
- 10.1097/01.SMJ.0000100117.79718.DC · DOI
- 2006, Annals of Internal Medicine, 145, 474, 10.7326/0003-4819-145-6-200609190-00021 · DOI
- 2008, Annals of Internal Medicine, 149, 516, 10.7326/0003-4819-149-7-200810070-00021 · DOI
- 1986, Journal of Chromatography, 383, 438
- 10.1124/dmd.32.6.647 · DOI · Paper page
- 10.1016/j.jpba.2007.02.034 · DOI
- 10.1124/dmd.105.008615 · DOI · Paper page
- 10.1055/s-2007-967172 · DOI
- 10.2165/00003088-200746080-00005 · DOI
- 2004, Current Hypertension Reports, 6, 300, 10.1007/s11906-004-0025-5 · DOI
- 10.1067/mcp.2001.115542 · DOI
- 10.1016/j.clpt.2006.09.003 · DOI · Paper page
- 10.2165/00003088-200847070-00003 · DOI
- 2003, Journal of Clinical Pharmacology, 43, 443, 10.1177/0091270003252519 · DOI · Paper page
- 10.1080/00498250802017715 · DOI
- 1993, American Journal of Hypertension, 6, 688, 10.1093/ajh/6.8.688 · DOI
- 10.1038/clpt.2008.195 · DOI · Paper page
- 10.1177/0091270011436344 · DOI
- 2002, Annals of Pharmacotherapy, 36, 288, 10.1345/aph.1A289 · DOI · Paper page
- 10.1046/j.1365-2125.2003.01833.x · DOI · Paper page
- 10.1124/jpet.104.068536 · DOI · Paper page
- 10.1007/s00228-002-0436-7 · DOI
- 10.1124/dmd.109.029132 · DOI · Paper page
- 10.1002/bdd.1795 · DOI
- 10.1056/NEJMoa0809171 · DOI · Paper page
- 10.1517/17425250903386251 · DOI
Cited by
The Use of Medications and Dietary Supplements by Masters Athletes—A Review
Harnett, J., Climstein, M., Walsh, J., & Gifford, J. (2022) · Current Nutrition Reports · doi:10.1007/s13668-022-00398-0 · Cited by 12
Metadata
- Authors
- Chen, C.-H., Uang, Y.-S., Wang, S.-T., Yang, J.-C., & Lin, C.-J.
- Venue
- Evidence-Based Complementary and Alternative Medicine
- Publisher
- Wiley
- Published
- 2012
- Volume
- 2012
- Pages
- 1-10
- ISSN
- 1741-427X
- 1741-4288
- Cited by
- 27
- References
- 2
- Language
- en
- Funders
- National Science Council (NSC 99-3114-B-002-001)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.